Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
Ebrahim Haroon, Andrew H. Miller, Gerard Sanacora
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 193-215
Open Access | Times Cited: 448

Showing 1-25 of 448 citing articles:

Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release
Shaimaa Mahmoud, Marjan Gharagozloo, Camille Simard, et al.
Cells (2019) Vol. 8, Iss. 2, pp. 184-184
Open Access | Times Cited: 541
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1469-1658
Open Access | Times Cited: 450
Microglial regional heterogeneity and its role in the brain
Yunlong Tan, Yi Yuan, Li Tian
Molecular Psychiatry (2019) Vol. 25, Iss. 2, pp. 351-367
Open Access | Times Cited: 411
Post-stroke depression: A 2020 updated review
Gustavo C. Medeiros, Durga Roy, Nicholas Kontos, et al.
General Hospital Psychiatry (2020) Vol. 66, pp. 70-80
Closed Access | Times Cited: 390
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Jennifer C. Felger
Current Neuropharmacology (2017) Vol. 16, Iss. 5, pp. 533-558
Open Access | Times Cited: 344
Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety
Mandakh Bekhbat, Gretchen N. Neigh
Brain Behavior and Immunity (2017) Vol. 67, pp. 1-12
Open Access | Times Cited: 278
Resilience and immunity
Robert Dantzer, Sheldon Cohen, Scott J. Russo, et al.
Brain Behavior and Immunity (2018) Vol. 74, pp. 28-42
Open Access | Times Cited: 263
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
Ludovica Iovino, Marie‐Ève Tremblay, Laura Civiero
Journal of Pharmacological Sciences (2020) Vol. 144, Iss. 3, pp. 151-164
Open Access | Times Cited: 263
Molecular pathways of major depressive disorder converge on the synapse
Gabriel R. Fries, Valeria Saldana, Johannes Finnstein, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 284-297
Open Access | Times Cited: 241
Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder
Ebrahim Haroon, Alexander W. Daguanno, Bobbi J. Woolwine, et al.
Psychoneuroendocrinology (2018) Vol. 95, pp. 43-49
Open Access | Times Cited: 231
Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders
Thomas D. Prévot, Etienne Sibille
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 151-167
Closed Access | Times Cited: 192
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 155
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Chadi G. Abdallah, Lynnette A. Averill, Ralitza Gueorguieva, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 990-997
Open Access | Times Cited: 151
Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
Ralph Francescone, Débora B. Vendramini‐Costa, Janusz Franco‐Barraza, et al.
Cancer Discovery (2020) Vol. 11, Iss. 2, pp. 446-479
Open Access | Times Cited: 147
Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Ebrahim Haroon, James R. Welle, Bobbi J. Woolwine, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 998-1007
Open Access | Times Cited: 139
How Inflammation Affects the Brain in Depression: A Review of Functional and Structural MRI Studies
Kyu‐Man Han, Byung‐Joo Ham
Journal of Clinical Neurology (2021) Vol. 17, Iss. 4, pp. 503-503
Open Access | Times Cited: 113
Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology
David R. Goldsmith, Mandakh Bekhbat, Neeti D. Mehta, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 5, pp. 405-418
Open Access | Times Cited: 108
Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease
Grzegorz A. Czapski, Joanna B. Strosznajder
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11677-11677
Open Access | Times Cited: 106
Molecular mechanisms of ischemia and glutamate excitotoxicity
Diogo Neves, Ivan L. Salazar, Ramiro D. Almeida, et al.
Life Sciences (2023) Vol. 328, pp. 121814-121814
Open Access | Times Cited: 82
Biological factors influencing depression in later life: role of aging processes and treatment implications
Sarah M. Szymkowicz, Andrew Gerlach, Damek Homiack, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 61
BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
Ana Salomé Correia, Armando Cardoso, Nuno Vale
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2081-2081
Open Access | Times Cited: 48
Astrocyte metabolism and signaling pathways in the CNS
Yong-Mei Zhang, Yingbei Qi, Ya-nan Gao, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 42
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 52-68
Open Access | Times Cited: 24
Immunotherapy for depression: Recent insights and future targets
Ying Bai, Yang Cai, Di Chang, et al.
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108624-108624
Closed Access | Times Cited: 16
The Role of Depressive Subtypes within the Neuroinflammation Hypothesis of Major Depressive Disorder
Marie Woelfer, Vanessa Kasties, Sascha Kahlfuß, et al.
Neuroscience (2018) Vol. 403, pp. 93-110
Closed Access | Times Cited: 142
Page 1 - Next Page

Scroll to top